PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This trial is an open, multi-center, phase Ic clinical study on the pharmacokinetics and drug
interactions of utidelone injection combined with capecitabine in patients with recurrent and
metastatic breast cancer.
The purpose of this trial is:
1. To evaluate the pharmacokinetic characteristics of continuous intravenous administration
of utidelone.
2. To evaluate the drug interaction of utidelone and capecitabine.